(2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
C17H21ClN4O5 — CID 172543505
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
(2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid (PubChem CID 172543505) has the molecular formula C17H21ClN4O5 and a molecular weight of 396.83 g/mol. Its IUPAC name is (2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid.
Molecular Properties
| Compound Name | (2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid |
|---|---|
| PubChem CID | 172543505 |
| Molecular Formula | C17H21ClN4O5 |
| Molecular Weight | 396.83 g/mol |
| Exact Mass | 396.12 |
| IUPAC Name | (2S)-3-[5-chloro-2-(1-methylpyrazol-4-yl)oxy-3-pyridinyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid |
| SMILES | Cn1cc(Oc2ncc(Cl)cc2C[C@H](NC(=O)OC(C)(C)C)C(=O)O)cn1 |
| InChI | InChI=1S/C17H21ClN4O5/c1-17(2,3)27-16(25)21-13(15(23)24)6-10-5-11(18)7-19-14(10)26-12-8-20-22(4)9-12/h5,7-9,13H,6H2,1-4H3,(H,21,25)(H,23,24)/t13-/m0/s1 |
| InChIKey | BOZOEYHZQPUYCQ-ZDUSSCGKSA-N |
| XLogP | 2.78 |
| TPSA | 115.57 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.83 |
| LogP ≤ 5 | 2.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172543505 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.